A mid-Western company is on the precipice of the greatest medical breakthrough in the history of mankind.
A breakthrough that will be more significant than the invention of every drug … every vaccination … and every medical device ... COMBINED.
You see, thanks to incredible technological advances, we are launching into a wondrous new age of medical discovery, the likes of which the world has never before seen.
The old, ineffective methods of treating patients in the 20th century are giving way to a new, highly targeted method that will transform the health care industry more than every breakthrough before it.
In fact, this new method will make diseases that were once considered “untreatable” or perhaps even “death sentences” … things of the past.
The end of all chronic diseases.
Yet, over the next few minutes, you will see the scientific evidence and meet people who are living healthy lives at this very moment as a result of this medical breakthrough.
It’s emerging at an unfathomable pace before our very eyes.
The dean of Stanford’s School of Medicine says, “The opportunities are enormous” … vice chair at Duke University’s Department of Surgery declares this is “changing the game” … and a University of Pennsylvania Wharton School of Business study calls this “a revolutionary approach to tackling disease.”
And it’s not just the top medical schools that see how remarkable this is.
Bill Gates, the co-founder of Microsoft, and Jeff Bezos, the founder of Amazon, are pumping millions into one of the companies involved in this breakthrough.
Congress even recently fast-tracked a radical new health care bill — called the 21st Century Cures Act — to ensure that nothing gets in the way of stopping what stands to be the biggest medicinal advancement in history.
The reason is simple…
No matter who you ask — scientists, doctors or researchers — the consensus is the same.
This breakthrough will be the BIGGEST story of the century.
It’s not just a game changer.
In fact, when this breakthrough was in its infancy, the scientific director of Harvard Medical School said: “At no time in the history of medical research, has there been more potential and promise that will benefit mankind.”
Today his statement is undeniable. Trust me … this breakthrough will have a profound impact on your life in the coming months and years, and it’s going to completely reshape the massive $1.7 trillion health care industry.
In a moment, I’ll share more details on this medical breakthrough, and just as importantly, I’ll tell you about the relatively unknown Mid-Western company at the forefront of it all that I am confident will make early investors an absolute fortune.
But first, it’s important for you to know who I am, and why I’ve never been so certain about anything in my professional career.
I am not a doctor.
I am not the head of a health research institute or a scientist from an Ivy League college.
However, I am a former Wall Street insider who has made millions for both myself and my privileged clients by spotting companies on the cusp of major medical breakthroughs.
My career began in 1991, when I started researching biotech stocks at Deutsche Bank. I quickly advanced to prominent positions at Bankers Trust and ING … I was eventually in charge of finding investment opportunities in health care stocks for a $150 billion fund. Under my guidance, I was able to find stocks that moved as much as $75 million in one day.
In 2006, I was recruited to head up a $6 billion hedge fund.
Soon after I joined, the firm’s assets under management soared ... to $25 billion.
Everyone took notice.
Barron’s named us as one of “World’s Best” funds, Kiplinger ranked us in the top 25, as a result I was invited to take part in a prestigious investment competition to see what I could do with $50 million.
Well, in one year, I was able to make a 76% return. Not too bad, considering I did this during the 2008 and 2009 economic crisis, and I did it without shorting stocks or making risky bets.
I won the competition and was thrust into the limelight.
I’ve appeared on CNBC, Fox Business News and Bloomberg TV, and yes, you’ve likely seen me on one of these programs before.
Of course, most people never knew about my personal gains. I’m going to show you those gains now, not to brag, but rather to prove to you that when it comes to identifying and seizing opportunities ... I know what I’m doing.
While most people were skeptical of Netflix early on, I wasn’t. Having insight into technological advancements, I knew the future of TV was streaming online video. I invested in October of 2008 and sold in May of 2010,
making a 634% gain.
I also saw a huge opportunity in Universal Display when it created organic LED technology. I discovered the opportunity very early on ... buying in September 2008, and selling in April of 2011 ... pocketing a 293% gain.
I made 264% on the 3-D company Stratasys.
I cashed out with a 279% gain on Facebook.
And I made a 327% gain on Olympus.
I made a 298% gain on Whole Foods…
A 269% gain on Cemex…
And a 266% gain on Grifols.
However, as great as these gains are, my biggest and often quickest gains come from companies that are on the forefront of major medical breakthroughs … such as the company I’ll be telling you about today.
For example, at Exact Sciences Corporation …
It’s a molecular diagnostics company with a focus on early detection and prevention of colorectal cancer.
I bought shares of the company for less than $5 and sold just above $15 … for a 355% gain.
Ariad Pharmaceuticals is another example.
This company is focused on breakthrough ways of discovering, developing and commercializing therapies for patients with rare cancers.
I scooped up shares of the company for just $6 and change. From there the stock soared, and just 22 months later, I sold in the mid-$20s for a gain of 696%.
I also uncovered a stock by the name of Sarepta Therapeutics when it was in the infancy stage of developing a drug to treat muscular dystrophy. I invested in April 2012, and I sold just eight months later, making a 2,539% gain.
And as great as these results are, I fully believe that this medical breakthrough I am telling you about today could make even bigger gains ... giving you the chance to turn every $1,000 into $76,000.
Of course, there are no guarantees in the financial markets. But the potential in this Mid-Western company at the forefront of this medical breakthrough is undeniable as it revolutionizes the $1.7 trillion health care industry. If it does only half of what I'm expecting, it will make you incredibly wealthy.
Imagine what you could do with those types of profits. Perhaps you would use that newfound money to retire earlier than you ever thought possible and buy that dream house you’ve always wanted.
That’s what I did.
After making all my gains, I retired at the age of 42 and moved into a country home located on the outskirts of Raleigh, North Carolina.
Fact is, I never did fit in on Wall Street.
I quickly grew tired of the corporate greed.
Tired of the 16-hour workdays.
Most of all, I was tired of missing the time I needed to be spending with my children.
So I walked away when I knew my family and I had plenty of money to live on.
Today, I have the privilege of bringing my kids to school and watching them compete in fencing and learn piano.
Of course, I’m still an investor.
Investing was ingrained in my mind as a child, when my father explained to me that it was the best way to get out of India’s rat race, where few can escape the lower class.
Indeed, it was my father who worked endlessly to put me in a private school and opened the doors to an American college.
Unfortunately, my father never got to see the level of success I achieved in my career.
He unexpectedly passed away from a heart attack when he was 66 years old. Nothing prepares you for the loss of a loved one. Suddenly, the security blanket you’ve clutched your whole life is taken away.
For me, my father’s death meant that my mentor and my best friend was gone.
However, as a long-time biotech investor, I knew the day would come when heart disease — and many other chronic diseases — could be defeated.
That day is today.
That’s why I’m so thrilled about the company behind this new medical breakthrough.
Millions of people … people whose lives are at the mercy of cancer, heart disease, Alzheimer’s, diabetes, Parkinson’s or another life-threatening disease … will no longer have to worry.
This medical breakthrough, and the company behind it, could usher in the end of all diseases.
Perhaps that’s why today, investing has taken a unique turn for me.
Not only do I look to find companies that will help Main Street Americans live free of disease, I also help Main Street Americans live free of financial fears.
You see ... when I was on Wall Street, I made money for the 1% ... such as European aristocracy, Swiss private banks and the Royal Bank of Scotland ... helping them turn millions into billions.
But now I help Main Street Americans find ways to turn thousands into hundreds of thousands, and there is no better way to do it than to show them how to invest in companies that are making big advancements in the medical field.
And I am doing it in a way that is truly revolutionary.
I’m allowing people — just like you — to virtually look over my shoulder at my own model portfolio so they can know exactly what I recommend folks buy, when to buy and when to sell. I’m also letting them in on my private chats with business insiders ... so they can be there with me as new opportunities unfold. It’s truly exciting.
Listen to what they have to say...
I also recently heard from a guy named Mitchell. He is an everyday investor who made $109,000 with just a single company I told him about.
Another gentleman was so thrilled with his results, he emailed me this snapshot of his brokerage account. Take a look
He made $77,150 on one position ... a gain of 799%. That’s more than most people make over the course of a year working full-time.
Another position brought in $31,965. That’s over $100,000, simply by following my lead and placing a trade within a matter of minutes.
Profits like these can be yours, too. In just a few moments, I’ll show you how you can join them. Anyone can use or simply follow my revolutionary way of investing.
But you have to get started now.
The last time I put out an alert like this was a year ago. Let me show you …
The company I recommended quickly shot up as much as 203% in just a few months.
However, it’s so potentially lucrative and moving so quickly that it could pass you by in a matter of days.
Those who are “ahead of the story” — those who invest before this technological breakthrough is used in every laboratory, every hospital and every medical center in the country — stand to make millions in a very short time.
It reminds me of one of the biggest biotech success stories in modern history … Celgene.
This biopharmaceutical company develops medicines for cancer and inflammatory disorders.
If you had invested in Celgene back on July 28, 1987 — the day Celgene went public and held it for 20 years — a $1,000 investment would be worth $76,000.
I think this opportunity could do the same for you … without having to invest in an IPO or take on unnecessary risk.
But it won’t take two decades for this to happen. This has the potential to happen in the next few years.
And the gains could be even bigger.
I know that’s a bold claim.
I hope it gives you pause.
But I also hope I’ve piqued your interest, because this medical miracle has the world’s greatest investors and most powerful governments chomping at the bit to participate in this breakthrough that is emerging at this very moment.
And you have the rare opportunity to get in on the ground floor with a Mid-Western company that’s on the cutting edge of this medical breakthrough.
You see, while thousands of biotech companies have been shooting for billion-dollar drugs … vaccinations … and medical devices, this innovative medical company has taken a very different route. It is reinventing health care from the nucleus up … and will soon dominate this $1.7 trillion industry.
Those with the vision to see the transformational impact of this breakthrough will enjoy a ride on the greatest economic wave the health care industry has ever seen.
Before I tell you more about this company, and how to position yourself before the mainstream catches wind, I need to let you in on a secret.
It’s the same secret I used when I was a key figure overseeing health care stocks at a $150 billion fund; it’s the same secret that helped me win the Investment Competition; and it’s the same secret that helped me make 6,220% in cumulative gains I showed you earlier.
It’s a secret I’ve kept hidden until now.
It’s a chart called the Innovation Acceptance Curve.
It has three phases.
This is when a new innovation comes to market.
It’s the “make it or break it” phase. Many innovations never make it out of this phase because even if they work, they never gain mass appeal.
This is where investors make a killing.
Find a company with a breakthrough that’s on the cusp of entering the acceptance phase … and generational wealth can be made.
At this point, practically everyone uses this innovation, and the biggest profits have been made.
The $1.5 billion Mid-Western company that is at the forefront of this medical breakthrough is right here, at the acceptance phase.
Hence the urgency, and enthusiasm, with this message. This innovative company is ready to take off, and I want you to have the opportunity to make life-changing gains.
Understanding this very simple diagram is what allowed me to spot an opportunity in Exact Sciences. The company’s early detection and prevention of colorectal cancer was entering Phase 2 … and I was able to invest and make gains of 355%.
Understanding the Innovation Acceptance Curve also gave me the chance to invest in Ariad Pharmaceuticals. Its treatment of rare cancers was entering Phase 2. I invested and made quick gains of 696%.
And Sarepta Therapeutics treatment of muscular dystrophy was also entering Phase 2. I invested and was rewarded with returns of 2,539%.
Nearly all of my gains have been made this way … even the gains I made in Netflix, Universal Display, Stratasys, Facebook, Olympus, Whole Foods, Cemex and Grifols.
The secret is to know when an innovation is going from Phase 1 to Phase 2. That’s why I still wake up at 5 a.m. every morning to do research, and it’s still why I have all the connections that I have.
For example, I know the New York Times best-selling finance author Nassim Nicholas Taleb, Nobel Prize winner Daniel Kahneman and the man who decoded the human genome, Craig Venter. I’ve even had private meetings with the founders of Gilead Sciences, Vertex Pharmaceuticals and Alexion Pharmaceutical, among many others.
No doubt, those who act fast will make unprecedented wealth.
I’ve never been more certain of anything in my 26-year career.
In a moment, I’ll tell you more about the Mid-Western company at the forefront of this health care revolution.
But first, you need to know a bit more about the science behind this breakthrough in order to understand how it will completely change the world.
To do this, I filmed a brief video back in my office with two of my colleagues. Take a look.
As you just saw, despite the fact that all humans have a 99.5% genetic similarity, my coat was too big for Amanda, and it was too small for Warren. The very idea of either of them fitting into my coat is quite ridiculous.
I tell you this because, just as it is no surprise that the outsides of our bodies are different, it should come as no surprise that the insides of our bodies are different too.
Yet, while we have tailor-made custom suits, we don’t have tailor-made custom medicine.
When it comes to medicine, we take the same pill or undergo the same treatment as everyone else, despite the fact that the insides of our bodies are VASTLY different from one person to the next.
You see, right now, doctors treat us with a one-size-fits-all approach.
When you go to the doctor, the first thing they do is take your blood pressure.
If you have high blood pressure … you’re prescribed a drug.
The scary part is, your doctor writes the same prescription for you, me, and every other patient who comes in and has high blood pressure.
But the problem with this “universal” approach to treating high blood pressure is that the medicine prescribed for it fails to help 50% of the time.
And this isn’t unique to high blood pressure. Take a look at these frightening statistics. The best medicine currently out there fails to help…
Now, I am not talking about over-the-counter medicine.
I’m talking about prescribed medicine, like the arthritis medicine Rituximab. It costs over $11,000 for a two-dose treatment … and it fails 50% of the time.
Because every person has a unique genetic makeup laid out by our DNA, and needs a genetically designed prescription.
It’s this DNA that determines your height… your weight … your eye color … whether you have curly or straight hair … and it can even predict if you will have a low or high IQ and so on.
This DNA also reveals if you are susceptible to a disease.
Until recently, it was virtually impossible to look inside each person and identify his or her DNA code … or it was incredibly expensive.
But all of that is changing.
Imagine looking at a person’s DNA, that person’s blueprint, and being able to design a medicine to fit that person’s specific genetic makeup … the same way you can custom tailor a suit to fit an individual … to prevent a disease from ever developing.
If that were possible … chronic diseases like arthritis, Alzheimer’s, diabetes, heart disease, Parkinson’s … could be wiped out simply by looking at a person’s DNA.
Well, this is where we are in history.
They now have the technology to map out a person’s DNA so doctors can personalize diets, medicines and treatments …. so diseases never develop.
This is the greatest achievement in medical history.
Possibly, the greatest achievement period.
This type of treatment gives a custom-tailored diagnosis and custom-tailored treatment that matches a person’s specific genetic makeup.
In a few years, the very idea of going to a drug store to buy an over-the-counter medicine will sound as silly as forcing everyone to wear the same size coat.
We will look back at our current medical practices the same way we look at the idea of bloodletting to cure illness or using leeches to extract diseases.
Hence, The Wall Street Journal says this kind of breakthrough will ignite “a health revolution.”
Precision medicine is individualized. It’s tailored precisely for a person’s specific genetic code. With this treatment, the right patient gets the right drug at exactly the right time.
In simple terms, precision medicine allows doctors to accurately identify which medicines and treatments will work best to prevent a patient from getting a particular disease … and which medicines and treatments will work best for a patient to overcome an existing disease … all based on a person’s genes.
As Dr. Marston Linehan, chief of urologic oncology at the National Cancer Institute, says: “It helps us decide what operation to do, whether to do an operation or not, what drug to give.”
Now, if you have the vision to see the massive societal impact this will have … you will be able to see that this is your opportunity to create a fortune so incredibly large — that it provides plenty of monetary gains for your family for generations to come.
Mark my words … precision medicine will revolutionize health care the same way Johannes Gutenberg revolutionized the written word, the same way Henry Ford revolutionized the auto industry, and the same way Steve Jobs revolutionized mobile phones.
Two well-known celebrities already credit precision medicine with saving their lives. The actress Angelina Jolie and basketball legend Kareem Abdul-Jabbar.
Ms. Jolie, as you may remember, not too long ago, announced that she had a preventative double mastectomy.
She had this procedure because of results from a precision medicine test. The results of this test showed that she had a mutation in her BRCA1 gene — which means that she had an 87% chance of developing breast cancer … and a 50% chance of ovarian cancer — the same disease that took the life of her mother, actress Marcheline Bertrand, at just 56 years old.
Now, thanks to precision medicine, Angelina’s likelihood of getting breast cancer is less than 5%.
And then there’s one of the greatest basketball players of all time, Kareem Abdul-Jabbar, the 19-time All Star, six-time MVP and the league’s all-time leading scorer.
Just a few years ago, Jabbar was diagnosed with leukemia, a cancer of the blood and bone marrow.
After having a genomic test done, he was treated with two targeted therapies … and today he’s alive and well as a result of precision medicine.
To understand how this works, let’s take a look at this chart on the origin of cancer…
What this reveals is that more than half of the most common cancers are traced back to specific genetic codes.
73% of melanoma, 56% of thyroid, 51% of colorectal, 43% of endometrial, 41% of lung cancer … hence some people can smoke their entire lives and never get lung cancer, while others can have the slightest exposure and get it.
From a medicinal standpoint, this will be huge for us.
Historically, cancer patients undergo chemotherapy … a treatment that kills ALL cells, even ones that are not cancerous.
But now a patient can receive treatment that only targets cells with cancer, thus increasing the success rate and limiting the side effects, giving patients a quicker recovery.
We’re not talking about just a new drug … or just a new treatment for cancer … we’re talking about a complete disruption of the $1.7 trillion health care industry.
Early results so far are nothing short of miraculous.
In fact, according to the Personalized Medicine Coalition, 73% of new cancer-treatment drugs currently in early stages of development are going to be using genetic data in their creation.
The Anderson Cancer Center performed a study on patients with end-stage diseases. They found that precision medicine increased the success rate of a cure by 440%.
The Indiana University of Health Precision Genomics Program did a similar study, and they had an 815% success increase for treating various cancers.
If it did that alone, we’re talking about hundreds of thousands of lives saved. But as I said, precision medicine will help people with every type of disease.
It’s unfolding in front of our very eyes.
A handful of Americans who were diagnosed with life-threatening diseases are new getting the treatment they need thanks to precision medicine.
Take, for instance, Andrew Patterson.
At 47, Andrew was diagnosed with Stage 4 lung cancer. As the tumors spread to his brain, he was desperate to see his children graduate from college and one day get married…
So rather than go under the knife to have the tumors removed, his oncologist recommended removing a tiny “swatch” of tumor tissue and have it sent off for genetic analysis.
Tests revealed Andrew has a protein-coding gene called ROS1. By identifying this gene, Andrew was able to start a personalized treatment plan with a drug that just months later had shrunk the tumors dramatically.
As Andrew says: “My six-centimeter mass went down to less than one. Today, at the age of 50, I'm living a phenomenal life.”
Wayne Eckhart is another example. He was diagnosed with cystic fibrosis at 8 years old. Wayne now lives a happy, healthy life because of a drug that treats the underlying cause of his cystic fibrosis, not his symptoms.
At a recent congressional briefing, Wayne told members of the U.S. Senate he now has hope and the strength to work to be healthier every day.
As Wayne says: "For the first time in my life, I truly believe that I will live long enough to be a grandfather.”
And then there’s Doreen Munson, who, at 57 years old, was diagnosed with chronic myeloid leukemia.
She was told there was an 80% chance she would die within two years.
After taking a drug tailored to her genes — her blood counts kept getting better and better.
Recently, Doreen received a call from her doctor saying that she had just 1% abnormal cells … and that she would live a long, normal life.
Precision medicine is now past Phase 1 and is entering Phase 2 as hospitals across the country are starting to implement precision medicine. In fact, a recent study reveals that 29% of hospitals surveyed have already begun implementing precision medicine to treat patients. Over the next few years, we will see incredible growth as 100% of hospitals use it to treat patients.
The market for this innovation will grow at an exponential rate — the likes of which the world has never witnessed.
And it’s just begun … with Congress fast-tracking the 21st Century Cures Act … and with the world’s smartest investors rushing to get a piece of the action.
I already mentioned that billionaires Bill Gates and Jeff Bezos are pumping millions into one company that’s using this medical breakthrough, but they are far from alone.
In fact, the smart money has begun flocking to companies in this new field in droves…
BlackRock, Vanguard, State Street and dozens of other venture capital firms are investing BILLIONS.
The list goes on and on.
It comes down to this…
The richest, smartest investors in America are loading up … and I encourage you to do the same immediately.
It’s just a matter of time before word gets out.
When that happens, and it will…
It will be too late. You’ll be left settling for the scraps of the newly rich.
Precision medicine is the future of health care.
And at the forefront of it all is an innovative biotech company that could hand early investors five, 10, 20, even 50 times their money.
Again, since retiring from Wall Street, I’ve made a lot of money tapping into the fastest-moving stocks on the planet ... without touching options or risky investments … and many of my biggest winners have come from medical breakthroughs.
I made 696% on Ariad Pharmaceuticals … I made 355% on Exact Sciences Corporation … and I made 2,539% on Sarepta Therapeutics.
But here’s the thing...
As remarkable as these gains are...
They pale in comparison to what you could make on the shift to precision medicine...
And while there will be a number of ways to profit in the coming years, there will NOT be another opportunity like the one before you today.
You see, the dawn of a new age of medical discovery is upon us.
This is the very beginning.
And a remarkable — yet overlooked — company is at the forefront.
This company is literally at the pulse of everything shaping precision medicine.
If you were to make only one biotech investment in the next decade, this should be the one.
I have absolutely no doubt.
It will be similar to when Celgene turned $1,000 into $76,000 … but the gains will come much more quickly.
Of course, there are no guarantees, but this innovative precision medicine firm could be the biggest winner the stock market has ever seen.
Here are the details...
It took 14 years to decode the first human gene at the price of $2.7 billion … and while prices have come down to less than $100,000, it’s really only the rich and the famous who can afford it … á la Angelina Jolie and Kareem Abdul-Jabbar.
Hence, for the last decade, precision medicine has been here on the Innovation Acceptance Curve.
But thanks to this Mid-Western firm’s technology that I’ve been telling you about today, precision medicine tests can now be done for a fraction of the cost… so that millions of Americans … and billions of people worldwide … can be tested.
Again, Congress recently passed the 21st Century Cures Act and now … accelerating this move … a full 97% of insurance companies have agreed to pay for precision medicine tests.
That means within months, millions of Americans from all walks of life will be lining up to get these tests done … using the tests to help them sidestep cancer, stop Alzheimer’s and prevent a heart attack.
Hence, BILLIONS of dollars could be flooding into this little-known company.
Thanks to this company, the $1.7 trillion health care industry is at a tipping point … their technology is about to hit a mass scale … moving into the acceptance phase…
Think about the societal impact this could have.
Think about ALL of the lives it could save.
And think about the millions that ground-floor investors stand to make.
Will you be among the winners?
The company my research has led me to stands to hand early investors much bigger profits than the $1,000 that biotech investors had the opportunity to turn into over $76,000.
Formed in the early 1990s, this Mid-Western-based company’s CEO is a 25-year biotech pioneer, and he’s using his industry contacts to bring some of the top scientific minds in the world to work in these hilltop facilities...
It is leading the industry in molecular diagnostic DNA sequencing to assess whether a person will develop a disease and to determine which drug therapy a person will best respond to.
More specifically, this company’s sequencing targets various forms of cancer, from ovarian to breast to lung to uterine to prostate, and rheumatoid arthritis.
Investing in this corporate pioneer today will position you perfectly for the chance to enjoy a ride on the greatest biotech innovation history has ever seen.
Fact is, even if this firm only captures a small portion of the nearly $2 trillion health care market, this $1.5 billion firm will see growth that’s through the roof … making five, 10, 20, even 50 times your money possible.
To give you an edge, I’ve put all the details in a special briefing called The Company Leading the Precision Medicine Revolution.
This report tells you everything you need to know about this innovative company, its products and how it will dominate its market, giving you the chance to turn every $1,000 into as much as $76,000.
I want to give it to you for free at the end of this presentation.
Again, precision medicine is in its infancy.
It’s going to revolutionize the $1.7 trillion health care industry.
This company is perfectly positioned to capture the lion’s share as 97% of insurance companies will pay for their tests.
As it leaps onto the scene with terrific force ... this firm is going to make the McDonald’s, Home Depots and Coca-Colas of the 20th century look like little “mom and pop” businesses.
And, I have no doubt, if you invest in this company today, you will have the chance to reap profits never before seen in stock market history.
There is no time to waste. This fast-moving shift to precision medicine is just beginning and the time to take action is NOW.
Again, my report called The Company Leading the Precision Medicine Revolution can be yours at no cost.
I want to give you this report for free, because I’ve spent the last 25 years of my life helping the uberwealthy turn millions of dollars into billions of dollars. Now I’m spending the next 25 years of my life showing Main Street Americans how they can turn thousands of dollars into hundreds of thousands of dollars.
It all started when a friend of mine, Sarah, approached me. She had inherited $500,000 from her father a few years after the 2008 crisis. She was terrified. Her father had worked hard, and the last thing she wanted to do was lose it.
She needed help and turned to me.
She knew my track record of success and knew that I hate risk.
I agreed to help Sarah navigate the market.
Soon after, Sarah doubled her money, making over $550,000.
She’s used those gains to pay off her mortgage and buy a second home. Best of all, she no longer worries about money.
After helping Sarah, other people in my town started seeking my insight. And I didn’t shy away from it. But it started to take up too much of my time.
If I wanted to help people, I knew I would have to find a better way to do it.
This research service allows you to look over my shoulder to see my model portfolio … my very best investment recommendations. You can become part of my “inner circle” — just like Sarah — and you’ll get access to my research ... and all of the investment opportunities I uncover each and every month.
This portfolio includes every stock that’s on my “buy now” list. I will typically recommend 12 new stocks every year. The portfolio will tell you what to buy, at what price to buy it and when to sell it. To be clear ... the portfolio will not just focus on precision medicine. I focus on all sectors of the market. If there is a chance to make “unlimited” profits ... I’m going to find it and recommend it. Over the last year alone, this portfolio is up 293% … that’s a sum of our wins and losses.
With these weekly updates, you will never be left in the dark. Every Tuesday, I will reach out to you. I will update you on our current positions and what’s happening in the markets.
And when it is time to make a trade, I will send you trade alerts via email. The email will tell you exactly what to do. And with today's technology, if you choose to invest, you can make the trade over your phone, desktop or tablet. It’s that easy.
My monthly briefings are my favorite part. Every month, I dive into a specific topic. Usually this topic revolves around a new investment I am targeting. I essentially take you with me as I meet with industry insiders and show you what I find as I conduct my forensic investigation on the stock.
You will also receive 24/7 access to my website. I keep all my latest information on an encrypted website that members can access at anytime, anywhere.
And of course, you get a dedicated customer service team. If you ever have questions about your membership, simply give one of my team members a call. They will walk you through whatever you need.
Like Sarah, you will never have to worry about another stock market crash wiping out your portfolio, you will no longer have to settle for paltry returns from funds weighed down by management fees and you will no longer have to second-guess your decisions.
A handful of people are already following my research ... people just like you … who had the chance to make total gains of 293% last year. Just listen to what they have to say about Profits Unlimited…
“Your recommendations have brought in over $26,000 in the last 3 months.” — Mike
“Your sound reasoning has surely produced results, and I couldn’t be happier … if my math is correct, I am up about $23K based on your recommendations. Not bad!” — Lars
“A profit of $45,190 … it’s amazing, thanks a million. During the last 30 years of fiddling with the stock market, I never came across any financial adviser who was as outstanding as you are.” — Bobby
“I wanted to express how happy I am since joining … I’m up some $70,000 in one position ... and another $40,000 on a second investment. I can’t say enough how the extra money will truly help me and my family.” — Jeff
“Somehow, you, your personality and your one-of-a-kind investment model convinced me to give up my fear and go ‘all-in’ … our account was worth $947,462. As I write this today, our account is valued at $1,654,508.” — Jeff and Vivian
Each of these persons were in your shoes at one point, and they decided to gain access to my research and my model portfolio … and they were rewarded with immense gains.
Now it’s your turn.
You’ve already seen the gains I made in my own portfolio … I’ll quickly show them again.
And while I’m thrilled these winners made cumulative gains of 6,220% … I’m confident they will look puny compared to what’s ahead.
With events quickly unfolding before our eyes, there’s never been a better time to join Profits Unlimited than now.
Precision medicine is on the verge of revolutionizing the $1.7 trillion health care industry ... and putting an end to chronic diseases … while giving you the chance to turn every $1,000 into as much as $76,000.
I don’t want anything holding you back from what’s at hand.
Helping you achieve an immense amount of wealth is my new mission. It brings me great joy to know that I can help others achieve their financial dreams.
Which is why I have kept the cost to join Profits Unlimited at the lowest level possible.
While people have paid me, literally, millions of dollars for my expertise, you don’t have to shell out a lot of money.
I’ve made my money. That’s not why I’m doing this.
The normal cost for access to this service and my research is just $199.
Frankly, it’s a steal at that price.
But to eliminate any and all barriers that could prevent you from joining, I’ve decided to offer the first 1,000 people today a risk-free trial to Profits Unlimited for only $47.
That’s less than it would cost to take your spouse to Outback Steakhouse.
However, I know we just met ... so you might be leery about joining my Profits Unlimited research service right now.
And again, I don’t want anything keeping you away from these massive gains.
Take the next 12 months to review everything I give to my Profits Unlimited readers. Take advantage of my stock recommendations … the same recommendations that made total gains of 293% last year and that have helped people make $70,000, $100,000 and even $700,000 … and profit from as many investments as you would like.
And if I don’t live up to your highest expectations, simply call my customer service team and you’ll receive every penny of your $47 membership fee back.
PLUS, you can keep all of the research and reports you receive to grow your wealth … including the report The Company Leading the Precision Medicine Revolution … free of charge..
In sum, you must be 100% satisfied, or you get every penny you pay back.
It doesn’t matter if my insight helps you make $100,000 … $1 million … or even $10 million. Or if you are just using it to learn more about the market. You must be 100% satisfied.
It doesn’t get any more risk-free than that.
So, if you’d like to join me through the precision medicine revolution ahead (and I hope you do) — and all the best profit opportunities I uncover as they emerge — the best thing to do now is to sign up for Profits Unlimited today.
You have so much to gain, and absolutely nothing to lose, by becoming the next member of my Profits Unlimited research service today.
Thank you so much for listening to this important presentation.
I sincerely hope you’ll take me up on this offer.
That’s because I know the precision medicine revolution will spawn more millionaires than any event in history ... and I want you to be among the few who will have the opportunity to make a lifetime’s worth of gains in a matter of months.
And it starts with this one company that’s at the center of it all.
Those who get in now, on the ground floor, could see five, 10, even 25 times their money, likely more...
But you need to act fast. The 21st Century Cures Act has passed, and 97% of insurance companies have agreed to cover the costs for millions of Americans to access these tests … hence, billions will be flooding into the company and its shareholders as the stock soars. The speed at which this emerging opportunity is moving will pass by those who hesitate.
Just click on the orange button below this video to get started.
This once-in-a-lifetime opportunity is yours for the taking.
I urge you to take advantage of it today.
I look forward to having you on board.